Actively Recruiting
Non-invasive Glioma Characterization Through Molecular Imaging
Led by University of Miami · Updated on 2026-04-20
30
Participants Needed
1
Research Sites
418 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
MRI-based sequences can provide non-invasive quantification of intratumoral 2-hydroxyglutarate (2HG) distribution and tumor cellularity in human gliomas and help guide the development of novel glioma therapies.
CONDITIONS
Official Title
Non-invasive Glioma Characterization Through Molecular Imaging
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults (18 years or older)
- Suspected or confirmed glioma diagnosis
- Scheduled for medically indicated biopsy or surgical removal of brain lesion
You will not qualify if you...
- Unable to consent
- Under 18 years old
- Pregnant women
- Unable to have MRI scan
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Miami
Miami, Florida, United States, 33136
Actively Recruiting
Research Team
N
Nathalie Padron
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here